Report #2829786

Received Mar 5, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 68 yrs
State: TX
Recovered: Unknown
Vaccinated: Feb 27, 2025
Onset: Feb 27, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	3	PC5Y3	—

Symptoms (1)

Extra dose administered

Symptom narrative

inadvertently administered with a third dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 68-year-old female patient who received Herpes zoster (Shingrix) (batch number PC5Y3, expiry date 30-JAN-2027) for prophylaxis. Previously administered products included Shingrix (received 1st dose on 23rd December 2023 of batch number N425G and expiry date of 7 December 2025) and Shingrix (received 2nd dose on 27 February 2024 of batch number 49EB3 and expiry date of 18 April 2026). On 27-FEB-2025, the patient received the 3rd dose of Shingrix. On 27-FEB-2025, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: inadvertently administered with a third dose). The outcome of the extra dose administered was not applicable. Additional Information: GSK Receipt Date: 27-FEB-2025 The patient inadvertently administered with a third dose of Shingrix, which led to extra dose administered.